Articles by Daniel Marsh
Caterpillar Nears 52-Week Peak Ahead of Key Events in Shortened Week
Caterpillar shares finished Friday's session at $774.20, up 2.1%, hovering close to a 52-week high. Markets are closed Monday for Presidents Day, with trading resuming Tuesday.
AI Chip Stocks Pause for Holiday, Nvidia Earnings Loom
Trading in artificial intelligence equities is on hold for the Presidents Day holiday, following a mixed session that saw Applied Materials surge on a strong forecast while Nvidia declined. Investor attention now turns to Nvidia's upcoming quarterly results and U.S. GDP data.
FTSE 100 Rises on NatWest Buyback; Mid-Caps Slump on Deal Fallout
The FTSE 100 advanced 0.3% to 10,473.69, buoyed by banking and defence shares. The FTSE 250 declined 0.2%, pressured by steep losses in Pinewood Technologies and SkinBioTherapeutics.
Norwegian Cruise Orders Three New Ships, Stock Drops on Capex Concerns
Norwegian Cruise Line Holdings has placed an order for three new ships with Italian shipbuilder Fincantieri for delivery in 2036 and 2037, triggering a 7.6% stock decline amid investor concerns over future capital expenditures.
Markets Pause for Holiday as Investors Eye CPI, Fed Minutes, Walmart
U.S. equity markets were closed Monday for the Presidents Day holiday, pausing after a mixed Friday session. Investors are assessing cooler inflation data and preparing for a week packed with Federal Reserve insights, economic reports, and earnings from retail giant Walmart.
ASX 200 Eyes Steady Start Amid BHP Earnings, RBA Minutes
The Australian share market is set for a modestly higher opening on Tuesday, with investor attention fixed on BHP's earnings and the Reserve Bank's latest meeting minutes.
Indian Indices Rebound on Bank, Energy Gains Amid Regulatory Concerns
Indian equity benchmarks snapped a two-day decline, with the Nifty 50 rising 0.83% and the Sensex gaining 0.79%, driven by strength in banking and energy shares.
Lilly's Retevmo Hits Trial Goal in Early Lung Cancer, Stock Reaction Awaited
Eli Lilly announced positive Phase 3 results for Retevmo in early-stage RET fusion-positive non-small cell lung cancer. U.S. market closure delays stock reaction until Tuesday.
J&J Shares Face Post-Holiday Pressure After Latest Talc Verdict
Johnson & Johnson shares closed lower Friday after a jury found the company liable in a baby powder cancer case, awarding $250,000. Investors await Tuesday's trading after the holiday, with the ex-dividend date approaching.


